Case Updates
Ninth Circuit holds that the reporting requirement in Oregon’s prescription drug pricing law is commercial speech, and that the internal pricing disclosure requirements in the statute survive intermediate scrutiny
August 26, 2025
U.S. Chamber files amicus brief urging Ninth Circuit to affirm that Oregon’s prescription drug pricing law violates the First Amendment and impermissibly compels speech by requiring public disclosure of information Oregon believes to be relevant to drug prices
September 11, 2024
Jeffrey S. Bucholtz and Matthew V. H. Noller of King & Spalding LLP served as outside counsel.